Mechanism Behind Pancreatic Cancer's Resistance to Chemotherapy Identified

A new mechanism that causes resistance of pancreatic cancer cells to chemotherapy has been discovered by University of Liverpool research team.

Pancreatic cancer is one of the leading causes of cancer death and current therapies are not very effective. Thus, a better understanding of the molecular mechanisms that impair the response of cancer patients to chemotherapy, the standard treatment of care for this disease, is essential to design more effective treatments for this lethal disease.

Pancreatic Cancer - All About the Disease, its Diagnosis and Management
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.

‘Tumor associated macrophages (TAM) and fibroblasts directly support chemotherapy resistance of pancreatic cancer cells by secreting insulin-like growth factors.’

Tweet it Now

Tumour associated macrophages (TAM) and fibroblasts are non-cancerous cells that are found within solid tumours, including pancreatic cancer. Accumulating evidence suggests that TAM and fibroblasts can support cancer progression, resistance to therapy and metastasis. However, the precise mechanisms by which these cells contribute to pancreatic cancer progression and response to therapy is not completely understood.

Chemo resistance

The research team led by Dr Ainhoa Mielgo Iza, a Sir Henry Dale Fellow, from the University's Institute of Translational Medicine, has been studying how these cells contribute to chemo resistance in pancreatic cancer.

Quiz on Pancreatic Cancer
Pancreatic cancer is often diagnosed at a late stage and can be fatal. Test your knowledge on pancreatic cancer by taking this quiz.

The study has been published in Cancer Research.

These proteins activate a survival signalling pathway on pancreatic cancer cells making them resistant to chemotherapy.

Potential Drug Targets to Reduce Pain in Pancreatic Cancer Patients
Blocking nerve growth factor keeps pancreatic cancer cells from invading surrounding nerves, revealed a new study.

Analysis of biopsies from pancreatic cancer patients revealed that this survival pathway is activated in 72% of the patients.

More effective treatment

Potential Pancreatic Cancer Target Identified
Over-expression of SLC6A14 protein in pancreatic tumors taken from patients and in cancerous pancreatic cells lines compared with normal pancreatic tissue.

Dr Mielgo, said: "These findings are very exciting because they uncover a mechanism that causes pancreatic cancer resistance to chemotherapy.

"Our research interest is to understand the complex interactions in the tumour microenvironment with the aim of finding new therapeutic targets for cancer.

"These results describe a combination treatment that could be more effective in treating this disease."

Source-Eurekalert